Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Medical Virology|January 8, 2019
Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccinePing Yang, Zhen Chen, Jieqiong Zhang, et al.
Vaccines|July 27, 2024
Comparison of the Immunogenicity of the LZ901 Vaccine and HZ/su Vaccine in a Mouse ModelYaru Quan, Chunxia Liu, Xu Lu, et al.
Frontiers in Immunology|July 8, 2024
Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequencyYanli Song, Jiaolei Wang, Zhihui Yang, et al.
Vaccine|December 6, 2023
Immunogenicity and safety of a live-attenuated varicella vaccine in a healthy population aged 13 years and older: A randomized, double-blind, controlled studyLili Huang, Zhen Chen, Yufei Song, et al.
Frontiers in Immunology|July 30, 2025
A novel adjuvant system BK-02 with CpG2006 and MF59 enhances the immunogenicity of a herpes zoster subunit vaccineZihan Wang, Yingnan Guo, Xin Tang, et al.
Human Vaccines & Immunotherapeutics|November 28, 2018
Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trialLili Huang, Zhen Chen, Yuansheng Hu, et al.
China CDC Weekly|October 31, 2025
Evaluation of Measles Vaccine Immunogenicity and Durability Using A Pseudotyped Virus Neutralization AssayQi Jiang, Xi Wu, Jie Zhang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 17, 2025
Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trialShenyu Wang, Pengfei Jin, Yaru Quan, et al.
The Pediatric Infectious Disease Journal|February 18, 2026
Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b TrialLingxian Qiu, Hongxing Pan, Qi Liang, et al.
Cell|August 12, 2020
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2Hui Wang, Yuntao Zhang, Baoying Huang, et al.
Pageof 2